Magnitude and duration of acute-exercise intensity effects on symptoms of restless legs syndrome: a pilot study

  • Katie L. Cederberg
  • Robert W. Motl
  • Timothy R. Burnham
Original Article
  • 29 Downloads

Abstract

Restless legs syndrome (RLS) is a neurological disorder that affects 5–15% of the population. There is increasing interest in exercise for managing the symptoms of RLS. To date, no research has examined the duration of acute-exercise intensity effects on RLS. The present study estimated the magnitude and duration of effect of two acute bouts of treadmill exercise at different intensities on severity of RLS. Eight participants (median age 44 years) with RLS completed three different conditions: rest, moderate-intensity exercise [50% heart rate reserve (HRR)], and vigorous-intensity exercise (70% HRR). RLS severity was measured with the International Restless Legs Syndrome Study Group (IRLS) Scale and daytime sleepiness was measured with the Epworth Sleepiness Scale (ESS) pre-condition, 24, and 48 h post-condition. There was no significant effect of time on IRLS or ESS for rest, moderate-intensity exercise, or vigorous-intensity exercise based on the Friedman test per condition. Effect sizes based on the z-value from the Wilcoxon Signed Ranks test indicated that moderate-intensity exercise had a moderate effect (r = 0.350) on IRLS in the first 24 h, but no effect on ESS. Vigorous-intensity exercise had a small effect on both IRLS (r = 0.191) and ESS (r = 0.210) in the first 24 h. Both conditions returned to normal or worsened within 48 h. Our results suggest that acute exercise, at either intensity, may have an immediate effect on RLS symptoms that dissipate within 48 h. These results highlight the importance of continual participation in exercise as a non-pharmacological approach to manage symptoms of RLS.

Keywords

Restless legs syndrome Daytime sleepiness Exercise Intensity Duration 

Notes

Acknowledgements

This study was completed in partial fulfillment of the first author’s Master’s degree.

Compliance with ethical standards

Conflict of interest

Katie L. Cederberg, Robert W. Motl, and Timothy R. Burnham declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    National Institute of Neurological Disorders and Stroke. NINDS restless legs syndrome information page. 2015.Google Scholar
  2. 2.
    Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, Ferini-Strambi L. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165:1286–92.CrossRefPubMedGoogle Scholar
  3. 3.
    Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164:196–202.CrossRefPubMedGoogle Scholar
  4. 4.
    Budhiraja P, Budhiraja R, Goodwin JL, Allen RP, Newman AB, Koo BB, Quan SF. Incidence of restless legs syndrome and its correlates. J Clin Sleep Med. 2012;8:119–24.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Ohayon MM, O’Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2012;16:283–95.CrossRefPubMedGoogle Scholar
  6. 6.
    Silber MH, Ehrenberg BL, Allen RP, Buchfuhrer MJ, Earley CJ, Hening WA, Rye DB. An algorithm for the management of restless legs syndrome. Mayo Clinic Proc. 2004;79:916–22.CrossRefGoogle Scholar
  7. 7.
    Allen RP, Bharmal M, Calloway M. Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States. Mov Disord. 2011;26:114–20.CrossRefPubMedGoogle Scholar
  8. 8.
    Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 2002;53:547–54.CrossRefPubMedGoogle Scholar
  9. 9.
    Sevim S, Dogu O, Camdeviren H, Bugdayci R, Sasmaz T, Kaleagasi H, Aral M, Helvaci I. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology. 2003;61:1562–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Winkelmann J, Wetter TC, Collado-Seidel V, Gasser T, Dichgans M, Yassouridis A, Trenkwalder C. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep. 2000;23:597–602.CrossRefPubMedGoogle Scholar
  11. 11.
    Sevim S, Dogu O, Kaleagasi H, Aral M, Metin O, Camdeviren H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry. 2004;75:226–30.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Koo BB, Bagai K, Walters AS. Restless legs syndrome: current concepts about disease pathophysiology. Tremor Other Hyperkinet Mov (N Y). 2016;6:401.Google Scholar
  13. 13.
    Takaki J, Nishi T, Nangaku M, Shimoyama H, Inada T, Matsuyama N, Kumano H, Kuboki T. Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis. 2003;41:833–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Dodel R, Happe S, Peglau I, Mayer G, Wasem J, Reese JP, Giani G, Geraedts M, Trenkwalder C, Oertel WH, Stiasny-Kolster K. Health economic burden of patients with restless legs syndrome in a German ambulatory setting. Pharmacoeconomics. 2010;28:381–93.CrossRefPubMedGoogle Scholar
  15. 15.
    Benes H, Heinrich CR, Ueberall MA, Kohnen R. Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial. Sleep. 2004;27:674–82.CrossRefPubMedGoogle Scholar
  16. 16.
    Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5:237–46.CrossRefPubMedGoogle Scholar
  17. 17.
    Silber MH, Becker PM, Earley C, Garcia-Borreguero D, Ondo WG. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc. 2013;88:977–86.CrossRefPubMedGoogle Scholar
  18. 18.
    Garcia-Borreguero D, Silber MH, Winkelman JW, Hogl B, Bainbridge J, Buchfuhrer M, Hadjigeorgiou G, Inoue Y, Manconi M, Oertel W, Ondo W, Winkelmann J, Allen RP. Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med. 2016;21:1–11.Google Scholar
  19. 19.
    Allen RP. Restless leg syndrome/Willis–Ekbom disease pathophysiology. Sleep Med Clin. 2015;10:207–214, xi.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Garcia-Borreguero D. Restless legs syndrome (Willis–Ekbom disease): an urgent need for better treatments. Sleep Med. 2017;30:266–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Mitchell UH. Nondrug-related aspect of treating Ekbom disease, formerly known as restless legs syndrome. Neuropsychiatr Dis Treat. 2011;7:251–7.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Aukerman MM, Aukerman D, Bayard M, Tudiver F, Thorp L, Bailey B. Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2006;19:487–93.CrossRefPubMedGoogle Scholar
  23. 23.
    Esteves A, de Mello M, Benedito-Silva A, Tufik S. Impact of aerobic physical exercise on restless legs syndrome. Sleep Sci. 2011;4:45–8.Google Scholar
  24. 24.
    Giannaki CD, Hadjigeorgiou GM, Karatzaferi C, Maridaki MD, Koutedakis Y, Founta P, Tsianas N, Stefanidis I, Sakkas GK. A single-blind randomized controlled trial to evaluate the effect of 6 months of progressive aerobic exercise training in patients with uraemic restless legs syndrome. Nephrol Dial Transplant. 2013;28:2834–40.CrossRefPubMedGoogle Scholar
  25. 25.
    Mortazavi M, Vahdatpour B, Ghasempour A, Taheri D, Shahidi S, Moeinzadeh F, Dolatkhah B, Dolatkhah S. Aerobic exercise improves signs of restless leg syndrome in end stage renal disease patients suffering chronic hemodialysis. Scientific World J. 2013:628142.Google Scholar
  26. 26.
    Sakkas GK, Hadjigeorgiou GM, Karatzaferi C, Maridaki MD, Giannaki CD, Mertens PR, Rountas C, Vlychou M, Liakopoulos V, Stefanidis I. Intradialytic aerobic exercise training ameliorates symptoms of restless legs syndrome and improves functional capacity in patients on hemodialysis: a pilot study. ASAIO. 2008;54:185–90.CrossRefGoogle Scholar
  27. 27.
    Giannaki CD, Sakkas GK, Karatzaferi C, Hadjigeorgiou GM, Lavdas E, Kyriakides T, Koutedakis Y, Stefanidis I. Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study. BMC Nephrol. 2013;14:194.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Giannaki CD, Sakkas GK, Karatzaferi C, Maridaki MD, Koutedakis Y, Hadjigeorgiou GM, Stefanidis I. Combination of exercise training and dopamine agonists in patients with RLS on dialysis: a randomized, double-blind placebo-controlled study. ASAIO. 2015;61:738–741.CrossRefGoogle Scholar
  29. 29.
    Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101–19.CrossRefPubMedGoogle Scholar
  30. 30.
    Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4:121–32.CrossRefPubMedGoogle Scholar
  31. 31.
    Benes H, Walters AS, Allen RP, Hening WA, Kohnen R. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord. 2007;22(Suppl 18):S401–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Thompson PD. ACSM’s new preparticipation health screening recommendations from ACSM’s guidelines for exercise testing and prescription, ninth edition. Curr Sport Med Rep. 2013;12:215–7.CrossRefGoogle Scholar
  33. 33.
    Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.CrossRefPubMedGoogle Scholar
  34. 34.
    Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992;15:376–81.CrossRefPubMedGoogle Scholar
  35. 35.
    Centers for Disease Control and Prevention. Current physical activity guidelines. 2016. https://www.cdc.gov/cancer/dcpc/prevention/policies_practices/physical_activity/guidelines.htm. Accessed 5 Dec 2017
  36. 36.
    Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, Sugawara K. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev. 2002;8:6–48.PubMedGoogle Scholar
  37. 37.
    Weinstock LB, Walters AS, Paueksakon P. Restless legs syndrome–theoretical roles of inflammatory and immune mechanisms. Sleep Med Rev. 2012;16:341–54.CrossRefPubMedGoogle Scholar
  38. 38.
    Kintz N, Petzinger GM, Jakowec MW. Treadmill exercise modifies dopamine receptor expression in the prefrontal cortex of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of Parkinson’s disease. Neuroreport. 2017;28:987–95.CrossRefPubMedGoogle Scholar
  39. 39.
    Lanza G, Bachmann CG, Ghorayeb I, Wang Y, Ferri R, Paulus W. Central and peripheral nervous system excitability in restless legs syndrome. Sleep Med. 2017;31:49–60.CrossRefPubMedGoogle Scholar
  40. 40.
    Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB. Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med. 2014;15:860–73.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Sleep Research 2018

Authors and Affiliations

  • Katie L. Cederberg
    • 1
  • Robert W. Motl
    • 1
  • Timothy R. Burnham
    • 2
  1. 1.Department of Physical TherapyUniversity of Alabama at BirminghamBirminghamUSA
  2. 2.Department of Nutrition and Exercise Health ScienceCentral Washington UniversityEllensburgUSA

Personalised recommendations